Apollo Hospitals shares in focus after reporting 63% YoY jump in Q2 net profit

Apollo Hospitals reported a 63% YoY jump in Q2FY25 net profit to Rs 379 crore, driven by strong hospital business growth. JP Morgan maintains an Overweight rating with a target price of Rs 7,200.

featured-image

Shares of Apollo Hospitals are likely to remain in focus as the company reported a 63% year-on-year (YoY) jump in net profit to Rs 379 crore in Q2FY25 , led by its hospital business. The company reported a net profit of Rs 233 crore in the corresponding quarter of the previous year. The earnings before interest, tax, depreciation and amortization (EBITDA), EBITDA rose 30% YoY to Rs.

816 crore in Q2FY25. The healthcare services business (hospital business) revenue grew 14% YoY to Rs 2,903 crore in Q2FY25. The EBITDA margins for the healthcare services business stood at 24.



9%. The overall occupancy for hospitals was at 73% vs 68% in the same period in the previous year, aided by a strong increase in patient flows across hospitals with inpatient (IP) volume increasing by 8.3% and outpatient (OP) new registrations by 10%.

Stock Trading ROC Made Easy: Master Course for ROC Stock Indicator By - Souradeep Dey, Equity and Commodity Trader, Trainer View Program Stock Trading Futures Trading Made Easy: Future & Options Trading Course By - Anirudh Saraf, Founder- Saraf A & Associates, Chartered Accountant View Program Stock Trading Complete Guide to Stock Market Trading: From Basics to Advanced By - Harneet Singh Kharbanda, Full Time Trader View Program Stock Trading Market 103: Mastering Trends with RMI and Techno-Funda Insights By - Rohit Srivastava, Founder- Indiacharts.com View Program Stock Trading Stock Investing Made Easy: Beginner's Stock Market Investment Course By - elearnmarkets, Financial Education by StockEdge View Program Stock Trading A2Z of Stock Market for Beginners: Stock Market Course For Beginners By - elearnmarkets, Financial Education by StockEdge View Program Stock Trading Commodity Markets Made Easy: Commodity Trading Course By - elearnmarkets, Financial Education by StockEdge View Program Stock Trading Renko Chart Patterns Made Easy By - Kaushik Akiwatkar, Derivative Trader and Investor View Program Stock Trading Point & Figure Chart Mastery: A Comprehensive Trading Guide By - Mukta Dhamankar, Full Time Trader, 15 Years Experience, Instructor View Program Stock Trading Heikin Ashi Trading Tactics: Master the Art of Trading By - Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert View Program Stock Trading Ichimoku Trading Unlocked: Expert Analysis and Strategy By - Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert View Program Stock Trading Market 104: Options Trading: Kickstart Your F&O Adventure By - Saketh R, Founder- QuickAlpha, Full Time Options Trader View Program Stock Trading Options Trading Made Easy: Options Trading Course By - Anirudh Saraf, Founder- Saraf A & Associates, Chartered Accountant View Program Stock Trading Options Trading Course For Beginners By - Chetan Panchamia, Options Trader View Program Stock Trading Algo Trading Made Easy By - Vivek Gadodia, Partner at Dravyaniti Consulting and RBT Algo Systems View Program Apollo Hospitals had 9,423 operating beds across the network. Diagnostics and retail healthcare business grew 14% YoY to Rs.

404 crore in Q2FY25. Apollo HealthCo - the digital healthcare and omni-channel pharmacy platform grew 17% YoY to 2,282 crore in Q2FY25. Post the Q2 results, global brokerage firm JP Morgan has maintained an Overweight rating on the stock with a target price of Rs 7,200 “Q2 results were broadly in line, and occupancy strength continued.

Healthy revenue growth was seen across segments. Strong occupancy was driven by healthy growth in IP/OP volumes. Hospital EBITDA margins improved, and a strong uptick in AHLL margins was seen,” said JP Morgan in its note.

The shares of Apollo Hospitals have increased by nearly 35% in the last one year while gaining 21.3% in the current year so far. In the last 6 months, the stock gained 15%.

The stock closed flat on Wednesday at Rs 6,969 on the BSE. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel ).